Princeton Global Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.86K Hold
87
﹤0.01% 649
2026
Q1
$5.46K Hold
87
﹤0.01% 674
2025
Q4
$5.77K Hold
87
﹤0.01% 660
2025
Q3
$5.85K Hold
87
﹤0.01% 608
2025
Q2
$7.59K Buy
+87
New +$6.82K ﹤0.01% 568
2021
Q1
Sell
-340
Closed -$31K 500
2020
Q4
$31K Hold
340
0.01% 281
2020
Q3
$35K Hold
340
0.01% 242
2020
Q2
$34K Hold
340
0.01% 285
2020
Q1
$23K Hold
340
0.01% 289
2019
Q4
$19K Buy
+340
New +$16.1K 0.01% 339
2019
Q3
Sell
-140
Closed -$5K 353
2019
Q2
$5K Buy
+140
New +$4.4K ﹤0.01% 346

Other funds holding DXCM

Princeton Global Asset Management's DXCM Position: Q2 2026 in Review

Princeton Global Asset Management held its DexCom (DXCM) position steady in Q2 2026 at 87 shares worth $5.86K. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Princeton Global Asset Management first reported a position in DXCM in Q2 2019 and has held it in 11 quarters since. The position peaked at $35K in Q3 2020. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Princeton Global Asset Management held 87 shares of DexCom worth $5.86K as of Q2 2026.
  • Princeton Global Asset Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #649 holding.
  • Princeton Global Asset Management first reported a position in DexCom in Q2 2019 and has held it in 11 quarters since.
  • Princeton Global Asset Management's DexCom position peaked at $35K in Q3 2020.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.